rs61754130
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 1P and 13B. PP2BP4_StrongBP6BS1BS2
The NM_001003800.2(BICD2):c.269A>G(p.Lys90Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00553 in 1,614,180 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001003800.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BICD2 | NM_001003800.2 | c.269A>G | p.Lys90Arg | missense_variant | 2/7 | ENST00000356884.11 | NP_001003800.1 | |
BICD2 | NM_015250.4 | c.269A>G | p.Lys90Arg | missense_variant | 2/8 | NP_056065.1 | ||
BICD2 | XM_017014551.2 | c.350A>G | p.Lys117Arg | missense_variant | 2/8 | XP_016870040.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BICD2 | ENST00000356884.11 | c.269A>G | p.Lys90Arg | missense_variant | 2/7 | 1 | NM_001003800.2 | ENSP00000349351.6 | ||
BICD2 | ENST00000375512.3 | c.269A>G | p.Lys90Arg | missense_variant | 2/8 | 1 | ENSP00000364662.3 |
Frequencies
GnomAD3 genomes AF: 0.00435 AC: 662AN: 152222Hom.: 3 Cov.: 33
GnomAD3 exomes AF: 0.00459 AC: 1151AN: 251024Hom.: 6 AF XY: 0.00480 AC XY: 651AN XY: 135674
GnomAD4 exome AF: 0.00566 AC: 8269AN: 1461840Hom.: 32 Cov.: 32 AF XY: 0.00565 AC XY: 4106AN XY: 727220
GnomAD4 genome AF: 0.00434 AC: 661AN: 152340Hom.: 3 Cov.: 33 AF XY: 0.00432 AC XY: 322AN XY: 74504
ClinVar
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 17, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | BICD2: BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Mar 03, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 23, 2019 | This variant is associated with the following publications: (PMID: 23664116, 27549087) - |
Hereditary spastic paraplegia Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Unit for Genetic & Epidemiological Research on Neurological Disorders, Instituto de Investigação e Inovação em Saúde | Mar 07, 2017 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Apr 21, 2017 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 18, 2020 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Neuronopathy, distal hereditary motor, autosomal dominant Benign:1
Benign, no assertion criteria provided | literature only | Inherited Neuropathy Consortium | - | - - |
BICD2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 30, 2022 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at